Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (181-190 of 302) with videos related to

Pageof 31
Sort By:
European Journal of Haematology|February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging PerspectivesGiulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Drug Design, Development and Therapy|July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of MyelomaFortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
Blood|December 7, 2006
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myelomaAntonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo, et al.
Leukemia & Lymphoma|August 23, 2008
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methodsEugenio Lucia, Bruno Martino, Corrado Mammi, et al.
Tumori|February 12, 2004
High-dose chemotherapy with mitoxantrone + melphalan and autologous stem cell rescue in metastatic breast cancer patients: a study of feasibility and tolerabilityMassimo Martino, Fortunato Morabito, Giuseppe Console, et al.
Current Drug Targets|August 12, 2009
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspectivePellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Leukemia & Lymphoma|September 16, 2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trialFortunato Morabito, Stefan Hohaus, Corrado Mammi, et al.
European Journal of Haematology|April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic MalignanciesSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Gene expression profiling of bone marrow endothelial cells in patients with multiple myelomaRoberto Ria, Katia Todoerti, Simona Berardi, et al.
Genes, Chromosomes & Cancer|June 4, 2011
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative studySonia Fabris, Oronzo Scarciolla, Fortunato Morabito, et al.
Pageof 31

Showing results (181-190 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Haematology|February 19, 2025
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging PerspectivesGiulio Caridà, Enrica Antonia Martino, Antonella Bruzzese, et al.
Drug Design, Development and Therapy|July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of MyelomaFortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
Blood|December 7, 2006
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myelomaAntonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo, et al.
Leukemia & Lymphoma|August 23, 2008
The incidence of JAK2 V617F mutation in bcr/abl-negative chronic myeloproliferative disorders: assessment by two different detection methodsEugenio Lucia, Bruno Martino, Corrado Mammi, et al.
Tumori|February 12, 2004
High-dose chemotherapy with mitoxantrone + melphalan and autologous stem cell rescue in metastatic breast cancer patients: a study of feasibility and tolerabilityMassimo Martino, Fortunato Morabito, Giuseppe Console, et al.
Current Drug Targets|August 12, 2009
First-line treatment of multiple myeloma in elderly patients: the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) multiple myeloma working party perspectivePellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Leukemia & Lymphoma|September 16, 2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trialFortunato Morabito, Stefan Hohaus, Corrado Mammi, et al.
European Journal of Haematology|April 27, 2026
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic MalignanciesSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
Gene expression profiling of bone marrow endothelial cells in patients with multiple myelomaRoberto Ria, Katia Todoerti, Simona Berardi, et al.
Genes, Chromosomes & Cancer|June 4, 2011
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative studySonia Fabris, Oronzo Scarciolla, Fortunato Morabito, et al.
Pageof 31